Advanced Therapy Medicinal Products (ATMPs)

Cell and gene therapy – where is the innovation? 

16 September 2022

Where globally is innovation occurring and what factors – industry, regulatory, and academia – are helping developers get their products to market? Here, DDW Editor Reece Armstrong explores the global hubs of innovation for cell and gene therapies. Since the approval of Kymirah in 2017, the cell and gene therapy sector has emerged as an […]

Insight: What to expect from SLAS Europe 2022

12 May 2022

Recent OBE recipient and SLAS Europe 2022 keynote speaker Steve Rees tells DDW’s Megan Thomas his thoughts on the themes of SLAS Europe 2022, the value of returning to face-to-face meetings, the influence the organisation has on his work and the industry’s key changes since the SLAS was formed in 2010. SLAS Europe 2022 themes […]

UK recognised as ATMP leader in clinical trials, report states

22 March 2022

The UK has been highlighted as a leader in clinical trials for Advanced Therapy Medicinal Products (ATMPs), after a report published by the Cell and Gene Therapy Catapult (CGT Catapult) displayed the sector’s continued growth in the UK. The report CGT Catapult’s 2021 Advanced Therapy Medicinal Product (ATMP) report shows that there were 168 ATMP […]